Related Experiment Video

Updated: Jul 6, 2026

Scanning Electron Microscopy of Macerated Tissue to Visualize the Extracellular Matrix
10:21

Scanning Electron Microscopy of Macerated Tissue to Visualize the Extracellular Matrix

Published on: June 14, 2016

[Cardiac involvement in Fabry's disease]

Frank Weidemann1, Frank Breunig

  • 1Medizinische Klinik und Poliklinik I, Herz- und Kreislaufzentrum, Universitätsklinikum, Julius-Maximilians-Universität Würzburg, Josef-Schneider-Strasse 2, Würzburg. weidemann_f@medizin.uni-wuerzburg.de

Medizinische Klinik (Munich, Germany : 1983)
|March 18, 2008
PubMed

Insights

Fabry's disease, a rare genetic disorder, causes harmful substance buildup in organs. This article reviews Fabry's cardiomyopathy, diagnostic methods, and enzyme replacement therapy.

Area of Science:

  • Genetics
  • Metabolic Disorders
  • Cardiology

Background:

  • Fabry's disease is a rare X-linked lysosomal storage disorder.
  • It results from globotriaosylceramide accumulation in lysosomes.
  • Progressive organ damage affects kidneys, brain, and heart.

Purpose of the Study:

  • To provide an overview of Fabry's cardiomyopathy.
  • To discuss essential cardiac diagnostic tests.
  • To introduce enzyme replacement therapy for Fabry's disease.

Main Methods:

  • Literature review on Fabry's disease and cardiomyopathy.
  • Analysis of diagnostic approaches for cardiac involvement.
  • Summary of current enzyme replacement therapy strategies.

Main Results:

  • Fabry's cardiomyopathy presents unique diagnostic challenges.
  • Cardiac manifestations require specific diagnostic tools.
  • Enzyme replacement therapy offers a novel treatment approach.

Conclusions:

  • Early diagnosis and management of Fabry's cardiomyopathy are crucial.
  • Comprehensive cardiac evaluation is essential for affected individuals.
  • Enzyme replacement therapy shows promise in managing Fabry's disease.

More Related Videos

In Vitro Enzyme Measurement to Test Pharmacological Chaperone Responsiveness in Fabry and Pompe Disease10:16

In Vitro Enzyme Measurement to Test Pharmacological Chaperone Responsiveness in Fabry and Pompe Disease

Published on: December 20, 2017

Refined CLARITY-Based Tissue Clearing for Three-Dimensional Fibroblast Organization in Healthy and Injured Mouse Hearts07:10

Refined CLARITY-Based Tissue Clearing for Three-Dimensional Fibroblast Organization in Healthy and Injured Mouse Hearts

Published on: May 16, 2021

Related Concept Videos

Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...